OTC: CASBF - CanSino Biologics Inc.

Yield per half year: +70.4%
Dividend yield: 0.00%
Sector: Healthcare

CanSino Biologics Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
9/10
10.28 31.91 -67.78% -2.82 -464.62%
P/S 14.94 3.22 363.39%
P/BV 0.9478 3.26 -70.91%
P/FCF -0.1602 19.77 -100.81%
Ev/Ebitda -3.82 10.21 -137.45%
Ev/S 16.82 1.89 791.85%
Ev/FCF -0.5634 17.78 -103.17%
E/P -0.8879 1.47 -160.45%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-440.11 24.68 -1883.62% -628.75 -30%
ROE -28.11 13.16 -313.61%
ROA -15.82 6.08 -360.12%
ROIC 23.82 15.56 53.09%
ROS -424.7 12.42 -3518.67%
ROCE -32.8 15.07 -317.7%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-1.65 6.27 -126.27% -1.4 +18.06%
Nеt Debt/Ebitda -0.4274 -5.69 -92.49%
Debt/Ratio 0.2701 0.2171 24.41%
Debt/Equity 2.34 12.61 -81.41%
Debt/Net Income -1.71 15.13 -111.28%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 1.73 -100% 1.78 -100%
Number of years of dividend growth 1 1.3 -22.83%
DSI 0.5 0.7924 -36.9%
Average dividend growth 0 -247.24 -100%
Average percentage for 5 years 1.78 2.81 -36.62%
Average percentage for payments 0.9658 247.93 -99.61%
Difference from average difference in sector -1.73

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
15017.08 96.77 15418.32%
Growth impulse Ebitda in 5 years 1092.96 78.13 1298.9%
Growth impulse Net Income in 5 years 845.82 88.81 852.39%
Growth impulse FCF in 5 years 3675.05 62.73 5758.52%
Growth impulse EPS in 5 years 2972.6 165.65 1694.51%
IP Score
5.53/10

Similar companies

WuXi Biologics (Cayman) Inc.

Sinopharm Group Co., Ltd.

Roche Holding

Sinopharm Group Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription